ZhuZhou QianJin Pharmaceutical Co.,Ltd

SHSE:600479 주식 보고서

시가총액: CN¥4.6b

ZhuZhou QianJin PharmaceuticalLtd 대차 대조표 상태

재무 상태 기준 확인 5/6

ZhuZhou QianJin PharmaceuticalLtd has a total shareholder equity of CN¥3.1B and total debt of CN¥46.8M, which brings its debt-to-equity ratio to 1.5%. Its total assets and total liabilities are CN¥4.5B and CN¥1.4B respectively. ZhuZhou QianJin PharmaceuticalLtd's EBIT is CN¥363.4M making its interest coverage ratio -9.4. It has cash and short-term investments of CN¥1.7B.

주요 정보

1.5%

부채 비율

CN¥46.83m

부채

이자 보상 비율-9.4x
현금CN¥1.73b
주식CN¥3.06b
총 부채CN¥1.39b
총 자산CN¥4.45b

최근 재무 상태 업데이트

업데이트 없음

Recent updates

재무 상태 분석

단기부채: 600479's short term assets (CN¥3.3B) exceed its short term liabilities (CN¥1.3B).

장기 부채: 600479's short term assets (CN¥3.3B) exceed its long term liabilities (CN¥94.2M).


부채 대 자본 내역 및 분석

부채 수준: 600479 has more cash than its total debt.

부채 감소: 600479's debt to equity ratio has increased from 0.9% to 1.5% over the past 5 years.

부채 범위: 600479's debt is well covered by operating cash flow (893%).

이자 보장: 600479 earns more interest than it pays, so coverage of interest payments is not a concern.


대차 대조표


건강한 기업 발견하기